Search
Search Results
##search.searchResults.foundPlural##
-
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4776Suppl. Files: 1305PDF: 1202Html: 354 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4547PDF: 1315HTML: 2496Figure 1: 242 -
ANTITHROMBOTIC PROPHYLAXIS IN THE MIDDLE EAST
2113PDF: 967HTML: 1410 -
-
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1785PDF: 1215HTML: 280 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
3064PDF: 1063HTML: 682 -
-
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
3040PDF: 1217HTML: 527Preferred Reviewers: 273 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3838PDF: 1252HTML: 23400 -
A MULTICENTER ICET-A SURVEY ON ADHERENCE TO ANNUAL ORAL GLUCOSE TOLERANCE TEST (OGTT) SCREENING IN TRANSFUSION-DEPENDENT THALASSEMIA (TDT) PATIENTS - THE EXPERT CLINICIANS’ OPINION ON FACTORS INFLUENCING THE ADHERENCE AND ON ALTERNATIVE STRATEGIES FOR ADHERENCE OPTIMIZATION Survey on adherence to annual OGTT in thalassemia
3098PDF: 1449HTML: 191 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4534PDF: 1492HTML: 2220 -
PEDIATRIC HODGKIN LYMPHOMA IN LOW- and MIDDLE-INCOME COUNTRIES (LMICs). A NARRATIVE REVIEW Pediatric Hodgkin's lymphoma in low-income countries
1468PDF: 1007HTML: 378 -
ACQUIRED REFRACTORY IRON DEFICIENCY
3891PDF: 1332HTML: 1686 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4511PDF: 1638HTML: 498 -
-
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
5035PDF: 1660HTML: 2291Untitled: 295Untitled: 313Untitled: 334Untitled: 287Untitled: 296 -
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ
1208PDF: 1010Suppl. Files: 634HTML: 119 -
TIMING FOR STEP-DOWN THERAPY OF CANDIDEMIA IN NON-NEUTROPENIC PATIENTS: AN INTERNATIONAL MULTI-CENTER STUDY Stepdown Therapy of Candidemia
2497PDF: 822HTML: 389 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2182PDF: 2059HTML: 816 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRANSFUSION-DEPENDENT β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATIONS Challenges in Supportive Care, Equity, and Compassion at End of Life
1341PDF: 928Html: 228 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3997PDF: 1212HTML: 2538Figure 1: 254 -
ULTRASOUND AS FIRST LINE STEP IN ANAEMIA DIAGNOSTICS
1609PDF: 1000HTML: 2036 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
341PDF: 430Suppl. Files: 92HTML: 197 -
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277976PDF: 1929HTML: 3921 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
5065PDF: 1936HTML: 2911Untitled: 359 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2903PDF: 1142HTML: 2419







